UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Crystal Structure of Phosphoserine BlaC from Mycobacterium tuberculosis Inactivated by Bis(Benzoyl) Phosphate

International journal of molecular sciences, 2019-07, Vol.20 (13), p.3247

2019

Volltextzugriff (PDF)

Structural, Biochemical, and Computational Characterization of Sulfamides as Bimetallic Peptidase Inhibitors

Journal of chemical information and modeling, 2024-02, Vol.64 (3), p.1030-1042

2024

Volltextzugriff (PDF)

Tunable pH-Sensitive Linker for Controlled Release

Bioconjugate chemistry, 2016-03, Vol.27 (3), p.824-830

2016

Volltextzugriff (PDF)

Phosphoramidate derivates as controlled-release prodrugs of l-Dopa

Bioorganic & medicinal chemistry letters, 2019-09, Vol.29 (18), p.2571-2574

2019

Volltextzugriff (PDF)

Tunable pH-sensitive 2-carboxybenzyl phosphoramidate cleavable linkers

Tetrahedron letters, 2020-03, Vol.61 (12), p.151650, Article 151650

2020

Volltextzugriff (PDF)

Second-Generation Tunable pH-Sensitive Phosphoramidate-Based Linkers for Controlled Release

Bioconjugate chemistry, 2016-09, Vol.27 (9), p.2206-2213

2016

Volltextzugriff (PDF)

Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403

Molecular imaging and biology, 2020-04, Vol.22 (2), p.274-284

2020

Volltextzugriff (PDF)

Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer

Journal of medicinal chemistry, 2016-06, Vol.59 (12), p.5684-5694

2016

Volltextzugriff (PDF)

Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities

The FEBS journal, 2016-01, Vol.283 (1), p.130-143

2016

Volltextzugriff (PDF)

Bis(benzoyl) phosphate inactivators of beta-lactamase C from Mtb

Bioorganic & medicinal chemistry letters, 2019-08, Vol.29 (16), p.2116-2118

2019

Volltextzugriff (PDF)

A method to determine the mode of binding for GCPII inhibitors using bio-layer interferometry

Journal of enzyme inhibition and medicinal chemistry, 2016-11, Vol.31 (6), p.1690-1693

2016

Volltextzugriff (PDF)

Structure–Activity Relationship of 18F‑Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer

Journal of medicinal chemistry, 2016-06, Vol.59 (12), p.5684-5694

2016

Volltextzugriff (PDF)

177 Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice

Theranostics, 2017, Vol.7 (7), p.1928-1939

2017

Volltextzugriff (PDF)

Rationally Designed Sulfamides as Glutamate Carboxypeptidase II Inhibitors

Chemical biology & drug design, 2013-11, Vol.82 (5), p.612-619

2013

Volltextzugriff (PDF)

Evaluation of Diarylureas for Activity Against Plasmodium falciparum

ACS medicinal chemistry letters, 2010-12, Vol.1 (9), p.460-465

2010

Volltextzugriff (PDF)

177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice

Theranostics, 2017-04, Vol.7 (7), p.1928-1939

2017

Volltextzugriff (PDF)

Dose optimization of ^sup 177^Lu-labeled phosphoramidate-based PSMA inhibitor with an albumin-binding motif (CTT1403) and therapeutic efficacy comparison to ^sup 177^Lu-PSMA-617

The Journal of nuclear medicine (1978), 2018-02, Vol.59 (2), p.363

2018

Volltextzugriff (PDF)

Stereoselective inhibition of glutamate carboxypeptidase by organophosphorus derivatives of glutamic acid

Bioorganic & medicinal chemistry, 2004-11, Vol.12 (22), p.6011-6020

2004

Volltextzugriff (PDF)

Second-Generation Tunable pH-Sensitive Phosphoramidate-Based Linkers for Controlled

Bioconjugate chemistry, 2016-09, Vol.27 (9), p.2206-2206

2016

Volltextzugriff (PDF)

Synthesis of Amino Acid Phosphoramidate Monoesters via H‐Phosphonate Intermediates

Current Protocols in Nucleic Acid Chemistry, 2006-07, Vol.25 (1), p.15.1.1-15.1.12

2006

Volltextzugriff (PDF)

Structure–Activity Relationship of 18 F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer

Journal of medicinal chemistry, 2016-06, Vol.59 (12), p.5684-5694

2016

Volltextzugriff (PDF)

Synthesis of individual glutamate-containing phosphonamidothionate stereoisomers

Tetrahedron letters, 2001-06, Vol.42 (26), p.4313-4316

2001

Volltextzugriff (PDF)

Alternatives to 1- H-tetrazole in the preparation of phosphonate diesters and phosphonamidates from phosphonyl dichlorides

Tetrahedron letters, 2004-08, Vol.45 (34), p.6497-6499

2004

Volltextzugriff (PDF)

Alternatives to 1-H-Tetrazole in the Preparation of Phosphonate Diesters and Phosphonamidates from Phosphonyl Dichlorides

ChemInform, 2004-12, Vol.35 (49), p.no-no

2004

Volltextzugriff (PDF)

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors

Annals of the rheumatic diseases, 2021-01, Vol.80 (1), p.36

2021

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(14)
Chemistry
(10)
Physical Sciences
(10)
Chemistry, Organic
(8)
Humans
(8)
Pharmacology & Pharmacy
(8)
Biochemistry & Molecular Biology
(7)
Chemistry, Medicinal
(7)
Animals
(6)
Amides - Chemistry
(5)
Glutamate Carboxypeptidase Ii - Antagonists & Inhibitors
(5)
Phosphoramidate
(5)
Phosphoric Acids - Chemistry
(5)
Chemistry, Multidisciplinary
(4)
Male
(4)
Mice
(4)
Molecular Structure
(4)
Albumin
(3)
Amides - Chemical Synthesis
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Crystal Structure of Phosphoserine BlaC from Mycobacterium tuberculosis Inactivated by Bis(Benzoyl) Phosphate

Structural, Biochemical, and Computational Characterization of Sulfamides as Bimetallic Peptidase Inhibitors

Tunable pH-Sensitive Linker for Controlled Release

Phosphoramidate derivates as controlled-release prodrugs of l-Dopa

Tunable pH-sensitive 2-carboxybenzyl phosphoramidate cleavable linkers

Second-Generation Tunable pH-Sensitive Phosphoramidate-Based Linkers for Controlled Release

Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403

Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer

Design of composite inhibitors targeting glutamate carboxypeptidase II: the importance of effector functionalities

Bis(benzoyl) phosphate inactivators of beta-lactamase C from Mtb

A method to determine the mode of binding for GCPII inhibitors using bio-layer interferometry

Structure–Activity Relationship of 18F‑Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer

177 Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice

Rationally Designed Sulfamides as Glutamate Carboxypeptidase II Inhibitors

Evaluation of Diarylureas for Activity Against Plasmodium falciparum

177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice

Dose optimization of ^sup 177^Lu-labeled phosphoramidate-based PSMA inhibitor with an albumin-binding motif (CTT1403) and therapeutic efficacy comparison to ^sup 177^Lu-PSMA-617

Stereoselective inhibition of glutamate carboxypeptidase by organophosphorus derivatives of glutamic acid

Second-Generation Tunable pH-Sensitive Phosphoramidate-Based Linkers for Controlled

Synthesis of Amino Acid Phosphoramidate Monoesters via H‐Phosphonate Intermediates

Structure–Activity Relationship of 18 F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer

Synthesis of individual glutamate-containing phosphonamidothionate stereoisomers

Alternatives to 1- H-tetrazole in the preparation of phosphonate diesters and phosphonamidates from phosphonyl dichlorides

Alternatives to 1-H-Tetrazole in the Preparation of Phosphonate Diesters and Phosphonamidates from Phosphonyl Dichlorides

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors

Suchergebnisse filtern